模拟琥珀酸(DMSA)螯合治疗铅中毒患者的效果
研究将双室琥珀酸动力学模型整合入现有PBPK铅模型,构建螯合铅治疗(CLT)模型,用于预测琥珀酸(DMSA)螯合治疗对血铅浓度的影响。通过模拟铅中毒并接受琥珀酸治疗患者的临床观察评估模型预测准确性,螯合前血铅浓度为99–150 μg/dL。模型能准确模拟琥珀酸治疗期间及治疗后的血铅浓度,部分患者尿铅排泄模式预测成功,另一些患者预测不佳。作者结论为:至少在铅暴露持续时间已知的情况下,该模型能预测琥珀酸治疗后的血铅浓度。
要点
- CLT模型将双室琥珀酸动力学模型整合入现有PBPK铅模型,用于预测琥珀酸螯合后血铅浓度。
- 模拟患者螯合前血铅浓度为99–150 μg/dL。
- 模型能准确模拟琥珀酸治疗期间及治疗后的血铅浓度。
- 尿铅排泄模式在部分患者中预测成功,在另一些患者中预测不佳。
- 模型预测血铅浓度的前提是铅暴露持续时间已知。
适用人群与场景
- 铅中毒并接受琥珀酸(DMSA)螯合治疗的患者,暴露来源为服用传统药物或职业性暴露于铅污染环境空气,且暴露持续时间已知。
研究设计与关键结果
- 研究类型为动力学模型构建与模拟验证研究;将双室琥珀酸动力学模型整合入现有PBPK铅模型,构建CLT模型。
- 模拟患者螯合前血铅浓度为99–150 μg/dL。
- CLT模型能准确模拟琥珀酸治疗期间及治疗后的血铅浓度。
- 尿铅排泄模式在部分患者中预测成功,在另一些患者中预测不佳。
- 模型将血铅浓度计算为背景暴露与急性或慢性铅中毒之和,后者归因于服用传统药物或职业性暴露于铅污染环境空气。
证据类型、等级与局限
- 证据类型为动力学模型构建与模拟验证研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在铅暴露持续时间已知的铅中毒患者中,CLT模型可预测琥珀酸螯合治疗期间及治疗后的血铅浓度。
- CLT模型对尿铅排泄模式的预测在部分患者中成功、在另一些患者中不佳,作者认为该模型至少在铅暴露持续时间已知的情况下能预测琥珀酸治疗后的血铅浓度。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
CONTEXT: Kinetic models could assist clinicians potentially in managing cases of lead poisoning. Several models exist that can simulate lead kinetics but none of them can predict the effect of chelation in lead poisoning. Our aim was to devise a model to predict the effect of succimer (dimercaptosuccinic acid; DMSA) chelation therapy on blood lead concentrations.
MATERIALS AND METHODS: We integrated a two-compartment kinetic succimer model into an existing PBPK lead model and produced a Chelation Lead Therapy (CLT) model. The accuracy of the model's predictions was assessed by simulating clinical observations in patients poisoned by lead and treated with succimer. The CLT model calculates blood lead concentrations as the sum of the background exposure and the acute or chronic lead poisoning. The latter was due either to ingestion of traditional remedies or occupational exposure to lead-polluted ambient air. The exposure duration was known. The blood lead concentrations predicted by the CLT model were compared to the measured blood lead concentrations.
RESULTS: Pre-chelation blood lead concentrations ranged between 99 and 150 μg/dL. The model was able to simulate accurately the blood lead concentrations during and after succimer treatment. The pattern of urine lead excretion was successfully predicted in some patients, while poorly predicted in others.
CONCLUSIONS: Our model is able to predict blood lead concentrations after succimer therapy, at least, in situations where the duration of lead exposure is known.
参考来源
- van Eijkeren JC, Olie JD, Bradberry SM, et al. Modeling the effect of succimer (DMSA; dimercaptosuccinic acid) chelation therapy in patients poisoned by lead. Clin Toxicol (Phila). 2016. PMID: 27919185. doi:10.1080/15563650.2016.1263855
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。